Heparin’s anticoagulant action protects the catheter lumen by strengthening antithrombin-mediated inhibition of thrombin and factor Xa. Thrombin and factor Xa participate in the pathway that produces fibrin, so limiting their activity reduces fibrin formation inside the access device. This mechanism explains why a dilute locking solution can support catheter patency between intermittent uses without requiring continuous infusion.
Heparin-induced thrombocytopenia is an important safety consideration because it can make continued heparin exposure inappropriate. The source specifically identifies HIT, along with bleeding risk, as a factor requiring attention. Consequently, clinicians should assess whether a heparin lock fits the patient and protocol, rather than treating catheter patency as the only objective.
Saline locking is preferred in some situations, so heparin should not be treated as the universal choice for intermittent catheter maintenance. The decision requires attention to the patient’s bleeding risk, potential heparin-induced thrombocytopenia, and the governing protocol. This comparison is clinically important because the selected locking approach must match the patient’s circumstances and the requirements for maintaining access.
Before use, the protocol should identify the heparin concentration, the volume placed in the catheter lumen, and the flushing technique. These details cannot be inferred from the purpose of the lock alone; they must be explicitly specified for the relevant clinical setting. Clear parameters support consistent administration after intermittent catheter use.
After medication administration or blood sampling, the solution is instilled into the catheter lumen according to the specified concentration, volume, and flushing technique. The lock is intended for intermittent access, so timing follows use of the catheter rather than a continuous infusion schedule. Local protocol determines the exact procedure and prevents unsupported assumptions about dosing or flushing.
Maintaining catheter patency between intermittent uses can preserve reliable vascular access and reduce the need for repeated catheter placement. That benefit matters when access is needed periodically rather than continuously. At the same time, clinicians must balance convenience with bleeding risk, heparin-induced thrombocytopenia, and situations in which saline locking is preferred.